Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation

Interplay between LXR and Wnt/ -Catenin Signaling in the Negative Regulation of Peripheral Myelin Genes by Oxysterols

(2011) J. Makoukji et al.   JOURNAL OF NEUROSCIENCE

Precise and global identification of phospholipid molecular species by an Orbitrap mass spectrometer and automated search engine Lipid Search

(2010) Ryo Taguchi et al.   JOURNAL OF CHROMATOGRAPHY A

Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models

(2010) Roman Chrast et al.   JOURNAL OF LIPID RESEARCH

Activation of the Liver X Receptor Increases Neuroactive Steroid Levels and Protects from Diabetes-Induced Peripheral Neuropathy

(2010) G. Cermenati et al.   JOURNAL OF NEUROSCIENCE

Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats

(2009) Marzia Pesaresi et al.   HORMONES AND BEHAVIOR

SCAP is required for timely and proper myelin membrane synthesis

(2009) Mark H. G. Verheijen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice

(2008) Tae-Il Jeon et al.   JOURNAL OF CLINICAL INVESTIGATION

Neuroactive steroids and peripheral neuropathy

(2007) Ilaria Roglio et al.   BRAIN RESEARCH REVIEWS

Evaluation of neuroactive steroid levels by liquid chromatography–tandem mass spectrometry in central and peripheral nervous system: Effect of diabetes

(2007) Donatella Caruso et al.   NEUROCHEMISTRY INTERNATIONAL